Ocugen shareholders approve increase in authorized common stock; two Class I directors elected

Ocugen, Inc.

Shankar Musunuri and Junge Zhang elected as Class I directors with 55.8M and 54.5M votes for.
Proposal to ratify Ernst & Young as independent auditor was withdrawn by the company.
Increase in authorized common stock approved: ~80.5B for, ~25.5B against.
Charter amendments to limit officer liability and adjust voting requirements not approved.
Advisory vote on executive compensation and adjournment proposal both approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.